Correspondence
Access Consortium: joint pipeline meetings
The Access Consortium is offering joint pipeline meetings to pharmaceutical and biotechnology companies.
Documents
Details
Pipeline meetings between our regulatory authorities and pharmaceutical and biotechnology companies are an opportunity to exchange information on new developments and collaborate on new possibilities.
The meetings will also help Access regulators plan and prepare for future work-share applications.
Updates to this page
Published 24 April 2023